Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
7.51
-0.07 (-0.92%)
At close: Mar 18, 2026, 4:00 PM EDT
7.75
+0.24 (3.20%)
After-hours: Mar 18, 2026, 7:19 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $463.09 million as of March 18, 2026. Its market cap has increased by 238.54% in one year.
Market Cap
463.09M
Enterprise Value
410.76M
1-Year Change
238.54%
Ranking
Category
Stock Price
$7.51
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $463.09M, an increase of 651.55%. That is a compound annual growth rate of 49.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 467.64M | 22.67% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 479.53M |
| Invivyd | 471.93M |
| Altimmune | 470.85M |
| Maravai LifeSciences Holdings | 461.11M |
| Assembly Biosciences | 454.58M |
| REGENXBIO | 453.68M |
| Relmada Therapeutics | 453.20M |
| Aclaris Therapeutics | 451.03M |